Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Patiromer 8.4 g sachet bulk supplier for pharma manufacturers

Patiromer 8.4 g Sachet 8.4g Suppliers & Bulk Manufacturers

Available Forms: sachet

Available Strengths: 8.4g

Reference Brands:

Category: Nephrology

Patiromer is an oral potassium binder that removes excess potassium through the gut, used for high blood potassium (hyperkalaemia) in kidney disease and in patients taking RAAS-inhibitor heart medicines. It comes as 8.4 g, 16.8 g and 25.2 g sachets mixed with water. The originator product is Veltassa; US generic entry is expected from 2027. Patent status differs by country, so we confirm what can lawfully be supplied to your destination before quoting.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Patiromer 8.4 g Sachet? List it or send an offer →

Product Description: Help decreasing serum potassium in patients with hyperkalemia

Patiromer 8.4 g Sachet — third party manufacturing & bulk supply

Patiromer 8.4 g Sachet 8.4g is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Patiromer 8.4 g Sachet is supplied as sachet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Patiromer 8.4 g Sachet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Patiromer 8.4 g Sachet →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

One sachet (starting at 8.4 g) mixed with water once daily with food; other oral medicines are taken at least 3 hours apart.

It starts lowering potassium within about 7 hours, so it is mainly used for chronic, not emergency, hyperkalaemia.

Refrigerated at 2–8 °C; it can be kept at room temperature for up to 3 months.

Related Products

Recombinant Human Erythropoietin Alfa Injection

Strength:
2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU

Form: Injection

Reference Brands: Epogen, Procrit(US), Eprex(EU)

View Details
Levocarnitine Injection

Strength:
1 g / 5 mL, 2 g / 10 mL, 330g, 500 mg

Form: injection , oral solution and tablets

Reference Brands: Carnitor (US)

View Details
Iron Sucrose Injection USP

Strength:
100mg/5ml

Form: Injection

Reference Brands: Venofer (US & EU)

View Details
Darbepoetin Alfa Injection

Strength:
10 mcg, 20 mcg, 30mcg, 40mcg, 50 mcg and 100 mcg

Form: Injection

Reference Brands: Aranesp (US & EU)

View Details
Sucroferric Oxyhydroxide Generics

Strength:
500mg

Form: Chewable Tablet

Reference Brands: Velphoro® (EU & US)

View Details
Sodium Zirconium Cyclosilicate Generics

Strength:
5g, 7g,10g sachets

Form: Powder for oral suspension

Reference Brands: Lokelma® (EU & US)

View Details
Methoxy Polyethylene Glycol-Epoetin Beta Generics

Strength:
25–250 mcg

Form: Solution for Injection

Reference Brands: Mircera® (US &EU)

View Details
Calcifediol

Strength:
30 mcg

Form: ER Oral Capsule

Reference Brands: Rayaldee®(US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us